1. India Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
Patidar Buildcon Ltd.

Patidar Buildcon Ltd.

BBSE:PATIDAR
6.48
INR
+0.30
(+4.85%)
-0.40EPS
34.63MMarket Cap
Patidar Buildcon Ltd.
BSE:PATIDAR
(Bombay Stock Exchange)

Recent

price

6.48

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
1.42
5.38
11.15
5.68
2.88
1.37
1.82
1.56
2.72
2.32
1.89
2.67
1.75
0.42
2.11
0.62
0.56
Revenue per Share
0.14
-2.84
0.05
0.3
0.11
0.38
0.47
0.92
0.12
-0.21
0.29
0.29
0.04
-0.17
-0.68
-0.43
-0.4
Basic EPS, GAAP
-2.26
1.86
-7.71
- -
0.64
1.74
3.74
-1.79
-0.54
-1.3
1.2
-0.79
-1.44
2.23
0.26
0.85
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
11.2
8.36
9.9
10.2
10.31
10.73
11.14
12.13
12.25
12.04
12.34
12.62
12.66
12.49
11.81
11.39
- -
Book Value per Share
11.2
8.36
9.9
10.2
10.31
10.73
11.14
12.12
12.25
12.04
12.34
12.62
12.48
12.15
11.63
11.09
- -
Tangible Book Value per Share
1
1
6
5
5
6
6
6
6
6
6
5
6
6
6
6
5
Basic Weighted Avg Shares
1
3
65
31
15
8
10
9
15
13
10
15
10
2
12
3
3
Sales/Revenue/Turnover
14.06
-52.71
0.7
7.69
1.05
-10.55
-8.23
81.8
-52.69
-40.2
-40.17
-13.97
-15.99
-144.8
-34.66
-110.86
-122.7
Operating Margin (%)
- -
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
-1
- -
2
1
2
3
5
1
-1
2
2
- -
-1
-4
-2
-2
Net Income, GAAP
32
- -
34.87
31.29
33.54
31.7
28.02
8.77
- -
- -
7.27
12.49
14.34
- -
- -
- -
- -
Effective Tax Rate (%)
9.56
-52.71
0.45
5.28
3.81
27.78
25.9
59.09
4.46
-9
15.62
10.87
2.3
-41.42
-32.19
-68.66
-72.17
Profit Margin (%)
3
2
26
49
43
52
59
58
52
53
48
48
35
25
17
10
- -
Working Capital
1
- -
- -
- -
- -
- -
- -
- -
6
6
- -
- -
35
25
22
18
- -
LT Debt
6
4
54
56
57
59
61
67
67
66
68
69
70
69
65
63
- -
Total Equity
1.01
- -
1
2.95
0.28
-0.43
-0.94
11.82
- -
- -
-6.19
-1.52
-1.03
- -
- -
- -
- -
Return on Invested Capital (%)
1.01
- -
1
2.95
1.05
3.5
4.17
7.94
- -
- -
2.31
2.3
0.21
- -
- -
- -
- -
Return on Capital (%)
1.22
-29.01
0.99
2.96
1.04
3.63
4.31
7.94
0.99
-1.72
2.42
2.3
0.32
-1.38
-5.58
-3.68
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
18
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
6
6
5
Market Capitalization
44
47
35

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
21
- -
Cash, Cash Equivalents & STI
- -
3
- -
Accounts Receivable, Net
- -
5
- -
Inventories
- -
13
- -
Total Current Liabilities
- -
11
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.66%
-1.55%
-3.61%
Free Cash Flow
-35.19%
-39.3%
227.25%
Net Income, GAAP
-84.9%
-73.66%
-37.09%
Sales/Revenue/Turnover
32.06%
52.32%
-70.5%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
3
5
3
12
2026
1
1
- -
1
3
2027
1
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.04
-0.14
-0.18
-0.31
-0.68
2026
-0.09
0.1
-0.18
-0.26
-0.43
2027
-0.06
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Similar Companies
Eli Lilly and Company (NYSE:LLY)
Novo Nordisk A/S (NYSE:NVO)
Johnson & Johnson (NYSE:JNJ)
Pfizer, Inc. (NYSE:PFE)
Dr. Reddy's Laboratories Ltd. (NSE:DRREDDY)
Divi's Laboratories Limited (NSE:DIVISLAB)
Business
Patidar Buildcon Limited is a construction and infrastructure development company primarily engaged in the construction of residential and commercial buildings, roads, highways, and other civil engineering projects. The company’s core products and services include project planning and execution; construction of multi-story buildings; road construction and maintenance; infrastructure development including bridges and flyovers; and real estate development services. It operates mainly in India, serving government and private sector clients across various states. Founded in 2007, Patidar Buildcon Limited is headquartered in Vadodara, Gujarat. In the past 1-2 years, Patidar Buildcon Limited has focused on expanding its operational footprint through strategic project acquisitions and entering into new construction segments. The company has strengthened its project portfolio by securing contracts for major urban infrastructure projects and has enhanced its service offerings by integrating advanced construction technologies and sustainable building practices. Additionally, Patidar Buildcon has established new partnerships aimed at leveraging innovation in construction methods to improve efficiency and project delivery timelines. These operational enhancements reflect the company’s strategic shift towards higher-value infrastructure projects and broader geographic coverage in India. Patidar Buildcon Limited operates within the construction and engineering industry with segments spanning civil infrastructure, urban development, and commercial real estate. Its customer base includes government bodies, private developers, and public sector enterprises. The company maintains various subsidiaries to support its diversified construction services. Patidar Buildcon’s comprehensive suite of services and recent strategic initiatives underscore its commitment to positioning itself as a leading infrastructure developer in India’s growing construction market.